Clinical Trial Update: A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C) [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for STX-1150 in participants with elevated LDL cholesterol/high cholesterol, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• STX-1150

Snippet

Sponsor: Monash University | Conditions: Elevated LDL-C and High Cholesterol | Phase 1 | Status: NOT_YET_RECRUITING